Previous studies have demonstrated the oncogenic role of TRAF6 in various cancers and the upregulation of TRAF6/NF-κB axis conferred chemoresistance of cancer cells [27, 28], however, the function of TRAF6 in association with paclitaxel resistance in cervical cancer has remained unclear. The gene discussed is TRAF6; the disease is cervical cancer.